← Back to all trials
Recruiting
NCT05805319
Dietary Intervention for NSCLC Patients Treated With ICI
Conditions: Non Small Cell Lung Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 80
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Location: Centre hospitalier de l'Université de Montréal (CHUM) Montreal Quebec
Summary
This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.
Eligibility Criteria
Inclusion Criteria:
* Signed, informed consent
* Age 18 years or older
* Confirmed histological diagnosis of non-small cell lung cancer (NSCLC); Treatment with standard-of-care ICI
* Ability to eat solid foods
Exclusion Criteria:
* Severe dietary allergies (e.g. shellfish, nuts, seafood)
* Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Source: ClinicalTrials.gov (NCT05805319). StuddyBuddy aggregates publicly available trial information.
